LSTA / Lisata Therapeutics, Inc. - Net Long/Short Value

Lisata Therapeutics, Inc.
US ˙ NasdaqCM ˙ US1280583022

LSTA / Lisata Therapeutics, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Founders Capital Management
SOL Capital Management CO
UBS Group AG
Renaissance Technologies Llc
Geode Capital Management, Llc
Bank Of America Corp /de/
Cheviot Value Management, LLC
Royal Bank Of Canada
Caitong International Asset Management Co., Ltd
BlackRock, Inc.
Susquehanna International Group, Llp
JBF Capital, Inc.
HighTower Advisors, LLC
PenderFund Capital Management Ltd.
Advisor Group Holdings, Inc.
Vanguard Fiduciary Trust Co
Vanguard Global Advisers, LLC
Tower Research Capital LLC (TRC)
Gts Securities Llc
Css Llc/il
Fortitude Family Office, LLC
Cerity Partners LLC
Vanguard Group Inc
SBI Securities Co., Ltd.
Northern Trust Corp
Virtu Financial LLC
Morgan Stanley
Vanguard Capital Management Llc
State Street Corp
Citadel Advisors Llc
Citigroup Inc
Deltec Asset Management Llc
Rangeley Capital, LLC
Connective Capital Management, LLC
International Assets Investment Management, Llc
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:8NE 2,96 €
GB:0HS8 3,14 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista